Nepafenac-associated bilateral corneal melt after photorefractive keratectomy

Cornea

Volumn 28, Issue 8, 2009, Pages 948-950

  Feiz, Vahid ^a   Oberg, Thomas J ^b   Kurz, Christopher J ^c   Mamalis, Nick ^c   Moshirfar, Majid ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Corneal melt; Corneal transplantation; Keratitis; Keratoplasty; Nepafenac; NSAID; PRK; Sterile ulcerative keratolysis

Indexed keywords

DEXAMETHASONE PLUS TOBRAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MOXIFLOXACIN; NEPAFENAC;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CONTACT LENS; CORNEA MELT; CORNEA STROMA; CORNEA TRANSPLANTATION; CORNEA ULCER; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; KERATOLYSIS; LASER; MALE; PENETRATING KERATOPLASTY; PHOTOREFRACTIVE KERATECTOMY; PHOTOSENSITIVITY; PRIORITY JOURNAL; VASCULITIS; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; CORNEAL STROMA; CORNEAL ULCER; DRUG ADMINISTRATION SCHEDULE; HUMANS; KERATOPLASTY, PENETRATING; MALE; PHENYLACETATES; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE CARE; REOPERATION;

EID: 69749116813     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318199e9cc     Document Type: Article

References (15)

1. Shahzad M, Gupta A, Pineda R. Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. Cornea. 2006;25:232-234.
2. Gabison E, Chastang P, Menashi S, et al. Late corneal perforation after PRK associated with topical diclofenac involvement of matrix metalloproteinases. Ophthalmology. 2003;110:1626-1631. (Pubitemid 36962500)
3. O'Brien TP, Qian JL, Sauerburger F, et al. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology. 2001;108:656-659. (Pubitemid 32238457)
4. Reviglio VE, Rana TS, Qian JL, et al. Effects of topical nonsteroidal anti-inflammatory drugs on the expression of matrix metalloproteinases in the cornea. J Cataract Refract Surg. 2003;29:989-997. (Pubitemid 36622674)
5. Guidera AC, Luchs JL, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108:936-944. (Pubitemid 32374251)
6. Takahashi N, Miyakoshi M, Taka N, et al. Cytotoxic effects of diclofenac sodium. Nippon Ganka Gakkai Zasshi. 1993;97:145-149.
7. Lin J, Rapuano C, Laibson P, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol. 2000;118:1129-1132. (Pubitemid 30643351)
8. Chen X, Gallar J, Belmonte C. Reduction by anti-inflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest Ophthalmol Vis Sci. 1997;98:1944-1952. (Pubitemid 27407513)
9. Nevanac (nepafenac ophthalmic 0.1%) Package Insert. Ft. Worth, TX: Alcon Laboratories, Inc, 2005.
10. Takahashi K, Saishan Y, Saishan Y, et al. Topical nepafenac inhibits ocular neovascularization. Invest Ophthalmol Vis Sci. 2003;44:409-415. (Pubitemid 36134303)
11. Di Pascuale M, Whitson J, Mootha V. Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery. Eye Contact Lens. 2008;34:129-130. (Pubitemid 351355193)
12. Congdon N, Schein O, von Kulajta P, et al. Corneal complications associated with topical ophthalmic use of non-steroidal anti-inflammatory drugs. J Cataract Refract Surg. 2001;27:622-631. (Pubitemid 33733436)
13. Reviglio VE, Hakim MA, Song JK, et al. Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC Ophthalmol. 2003;3:10.
14. Wolf EJ, Kleiman LZ, Shrier A. Nepafenac-associated corneal melt. J Cataract Refract Surg. 2007;33:1974-1975.
15. Bekendam P, Narvaez J, Agarwal M. Case of cornea melting associated with use of topical nepafenac. Cornea. 2007;26:1002. (Pubitemid 47329811)